FREE SHIPPING*
MONEY BACK GUARANTEE
30-DAY FREE RETURNS
12-Month Warranty
Products
IQbuds
²
MAX
IQstream TV
Bluetooth Transmitter
IQBUDS Spare Parts
Hearing Solutions
Reviews
Hearing Check
Support
Shop Now
Shop
Select Page
ASX Announcements
April 28th, 2023 -
Nuheara Executive Appointments and Restructured Global Team to Maximise Growth Opportunities
April 28th, 2023 -
Nuheara Limited (ASX: NUH) Q3 FY23 Update [Audio Recording]
February 28th, 2023 -
Nuheara Expands with Target.com in the US and Ships HP Hearing PRO
February 21st, 2023 -
Nuheara To Distribute HP Hearing PRO Through Fuel Medical
February 16th, 2023 -
Nuheara Commences Mass Production of HP Hearing PRO with Shipping Expected this Month
February 8th, 2023 -
Quarterly Activities Report and Appendix 4C, 31 December 2022
December 22nd, 2022 -
Nuheara raises over $3 MILLION to underpin US growth. – 22 December 2022
December 12th, 2022 -
Nuheara Expands U.S. Retail Footprint with InnerScope Strategic Partnership – 12 December 2022
November 2nd, 2022 -
Nuheara (NUH) Investor Briefing – SYD Nov 2, 2022 Canberra, Melbourne, Sydney
October 31st, 2022 -
2023 FY Q1 Results – Webinar 31 October 2022
October 31st, 2022 -
Quarterly Activities Report and Appendix 4C – 31 October 2022
October 31st, 2022 -
NUHEARA RECEIVES HISTORIC FDA CLEARANCE FOR SELF-FITTING OTC HEARING AID AND LAUNCHES HP HEARING PRO
October 6th, 2022 -
2022 AGM Key Dates – 06 OCTOBER 2022
September 16th, 2022 -
Appendix 3G: Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
September 5th, 2022 -
Nuheara Limited (ASX: NUH) – Suspension from Quotation – 05 September 2022
September 1st, 2022 -
Nuheara Limited ASX:NUH – Trading Halt 01 September 22
August 23rd, 2022 -
Results of General Meeting of Shareholders, 22 August 2022
August 17th, 2022 -
US OTC HEARING AID MARKET TO OPEN FOR NUHEARA
July 29th, 2022 -
Becoming a substantial holder
July 29th, 2022 -
Quarterly Activities and Cash Flow Report – quarter ended 30 June 2022
July 27th, 2022 -
s708A Cleansing Notice
July 27th, 2022 -
Appendix 2A – Application for the Quotation of Shares
July 27th, 2022 -
Notice of Initial Substantial Holder
July 22nd, 2022 -
APPOINTMENT OF AUDITOR
July 21st, 2022 -
NOTICE OF GENERAL MEETING AND EXPLANATORY MEMORANDUM TO SHAREHOLDERS
July 21st, 2022 -
GENERAL MEETING – NOTICE AND PROXY FORM
July 19th, 2022 -
Appendix 2A: Bergen Share Issue
July 19th, 2022 -
Appendix 2A: Directors’ Salary Sacrifice Shares
July 19th, 2022 -
Appendix- 2A Realtek
July 16th, 2022 -
Appendix 3Y: Change of Directors’ Interest Notice x 4
July 16th, 2022 -
Sec 708A Cleansing Notice
July 16th, 2022 -
Sec 708A Cleansing Notice
July 16th, 2022 -
Appendix 2A: Directors’ Salary Sacrifice Shares
July 16th, 2022 -
Appendix 2A: Bergen Share Issue
July 16th, 2022 -
Appendix 2A: Realtek Shares
July 6th, 2022 -
Notification of cessation of securities – NUH
July 1st, 2022 -
Section 708A(5)(e) Notice
July 1st, 2022 -
NUH Strategic Partner & Cornerstone Investment with Realtek
July 1st, 2022 -
Reinstatement to Official Quotation
July 1st, 2022 -
Application for quotation of securities – NUH
June 8th, 2022 -
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
May 25th, 2022 -
AGREEMENT FOR THE SALE OF NON-CORE MINING ROYALTY[42]
May 24th, 2022 -
Appendix 4C: Quarter Ended 31 March 2022 – Amended
May 9th, 2022 -
Nuheara Announces New CEO and Roth Capital to Explore US Listing
May 3rd, 2022 -
2022 FY Q3 Results – Webinar & Presentation Slides
May 3rd, 2022 -
Quarterly Activities Report and Appendix 4C
April 29th, 2022 -
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
April 27th, 2022 -
RESULTS OF GENERAL MEETING OF SHAREHOLDERS
April 27th, 2022 -
Section 708A(5)(e) Notice
April 27th, 2022 -
Appendix 2A – Application for Quotation of Securities
April 26th, 2022 -
Nuheara Enters Worldwide Trademark License Agreement With HP Inc.
April 12th, 2022 -
NUHEARA SUBMITS 510(k) FOR U.S. FDA CLEARANCE
March 28th, 2022 -
NUH – Notification of Consolidation/Split
March 25th, 2022 -
NUH EGM Letter to Shareholders – Notice of Meeting and Proxy Form
March 25th, 2022 -
NOTICE OF GENERAL MEETING AND EXPLANATORY MEMORANDUM TO SHAREHOLDERS
March 25th, 2022 -
Appendix 3H Notification of Cessation of Securities
February 28th, 2022 -
Half Year Ended 31 December 2021 – Nuheara Well Placed To Grow
February 16th, 2022 -
NUHEARA EXPANDS US OPERATIONS TO CAPTURE REGULATED HEARING MARKET OPPORTUNITY
February 9th, 2022 -
S708A(5)(e) Cleansing Notice
February 9th, 2022 -
Appendix 2A – Application for Quotation of Securities
February 1st, 2022 -
2022FY Q2 Results – Webinar & Presentation Slides
February 1st, 2022 -
Clinical Trial Validates Hearing Benefits of Nuheara’s Self-Fitted Hearing Aids & Software
January 31st, 2022 -
Quarterly Activities Report – For the quarter ended 31 December 2021
January 28th, 2022 -
Q2 FY22 Business Update and Investor Briefing Details
January 28th, 2022 -
Appendix 3Y – Change of Director’s Interest Notice
January 25th, 2022 -
Appendix 2A – Application for quotation of securities
January 24th, 2022 -
Nuheara Completes Share Purchase Plan
January 6th, 2022 -
Nuheara Clinical Trial and FDA 510(K) Pathway Update
January 5th, 2022 -
Section 708A(5)(e) Notice (cleansing notice)
January 5th, 2022 -
Appendix 2A – Application for quotation of securities
January 4th, 2022 -
Appendix 3B – CN Cap Raising & SPP_231221
January 4th, 2022 -
Nuheara Undertakes Capital Raising to Support Growth